Using Facebook to help American Indian women recover from opioid use
Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 2)
This study is testing whether a Facebook group can help American Indian women who are recovering from opioid use feel more supported and connected during their recovery journey.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT05995886 on ClinicalTrials.gov |
What this trial studies
This study aims to determine the effectiveness of a Facebook group designed to support American Indian women in their recovery from opioid use disorder. Participants will engage in a community-based intervention that leverages social media to foster connection and support among individuals in recovery. The study will include women who self-identify as American Indian or Alaska Native, are at least 18 years old, and have been abstinent from opioids for at least one month. The intervention will last for three months, during which participants will have access to resources and peer support through the Facebook group.
Who should consider this trial
Good fit: Ideal candidates for this study are American Indian or Alaska Native women aged 18 and older who have been abstinent from opioids for at least one month and are currently using medication for opioid use disorder.
Not a fit: Patients who are currently experiencing suicidality or do not have access to the internet or a Facebook account may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a valuable support network for American Indian women recovering from opioid use disorder.
How similar studies have performed: Other studies have shown promise in using social media for support in recovery, indicating that this approach may be effective, though this specific intervention is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. AIAN person based on self-reported race/ethnicity 2. Gender identity as a woman 3. At least 18 years of age with no upper age limit 4. Resides in Minnesota 5. Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013) 6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen 7. Current use of MOUD 8. Is comfortable speaking and reading English 9. Has an existing Facebook account or willing to set one up 10. Is willing and able to participate in the Facebook intervention for 3 months 11. Has access to broadband internet on a mobile phone/computer/tablet at any location 12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit. 13. Provides written informed consent Exclusion Criteria: 1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale 2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123
Where this trial is running
Rochester, Minnesota
- Mayo Clinic — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Christi A Patten, PhD — Mayo Clinic
- Study coordinator: Ashley Brown
- Email: wiidookaagewin@mayo.edu
- Phone: 1-833-880-2600
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.